CVS Health Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 increased by 3.6% to $4.70B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.7%, from $4.83B to $4.70B.
other_available_for_sale_securities_debt_maturities_afte_0f7586| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.13B | $5.03B | $4.98B | $4.63B | $4.41B | $4.28B | $4.59B | $4.42B | $4.83B | $4.42B | $4.53B | $4.70B |
| QoQ Change | — | -1.9% | -1.0% | -7.1% | -4.7% | -2.9% | +7.2% | -3.7% | +9.2% | -8.4% | +2.5% | +3.6% |
| YoY Change | — | — | — | -9.8% | -12.4% | -14.1% | -0.8% | +0.3% | +12.8% | -3.6% | +2.6% | -2.7% |